Student or educator? Sign up with your school email and get 6 months of Pro free.

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension

Abstract

Background Isolated systolic hypertension occurs in about 15% of people aged 60 years or older. In 1989, the European Working Party on High Blood Pressure in the Elderly investigated whether active treatment could reduce cardiovascular complications of isolated systolic hypertension. Fatal and non-fatal stroke combined was the primary endpoint.Methods All patients (> 60 years) were initially started on masked placebo. At three run-in visits 1 month apart, their average sitting systolic blood pressure was 160-219 mm Hg with a diastolic blood pressure lower than 95 mm Hg. After stratification for centre, sex, and previous cardiovascular complications, 4695 patients were randomly assigned to nitrendipine 10-40 mg daily, with the possible addition of enalapril 5-20 mg daily and hydrochlorothiazide 12.5-25.0 mg daily, or matching placebos. Patients withdrawing from double-blind treatment were still followed up. We compared occurrence of major endpoints by intention to treat.Findings At a median of 2 years' follow-up, sitting systolic and diastolic blood pressures had fallen by 13 mm Hg and 2 mm Hg in the placebo group (n = 2297) and by 23 mm Hg and 7 mm Hg in the active treatment group (n = 2398). The between-group differences were systolic 10.1 mm Hg (95% CI 8.8-11.4) and diastolic, 4.5 mm Hg (3.9-5.1). Active treatment reduced the total rate of stroke from 13.7 to 7.9 endpoints per 1000 patient-years (42% reduction; p = 0.003). Non-fatal stroke decreased by 44% (p = 0.007). In the active treatment group, all fatal and non-fatal cardiac endpoints, including sudden death, declined by 26% (p = 0.03). Non-fatal cardiac endpoints decreased by 33% (p = 0.03) and all fatal and non-fatal cardiovascular endpoints by 31% (p < 0.001). Cardiovascular mortality was slightly lower on active treatment (-27%, p = 0.07), but all-cause mortality was not influenced (-14%; p = 0.22).Interpretation Among elderly patients with isolated systolic hypertension, antihypertensive drug treatment starting with nitrendipine reduces the rate of cardiovascular complications. Treatment of 1000 patients for 5 years with this type of regimen may prevent 29 strokes or 53 major cardiovascular endpoints.

Overview

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(97)05381-6

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Cited by

See all 2,989

Metadata

Authors
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., Forette, F., Leonetti, G., Nachev, C., O' Brien, E. T., Rosenfeld, J., Rodicio, J. L., Tuomilehto, J., & Zanchetti, A.
Affiliations
  • KU Leuven (BE)
  • Erasmus University Rotterdam (NL)
  • University of London (GB)
  • London School of Hygiene & Tropical Medicine (GB)
  • Université Paris Cité (FR)
  • University of Milan (IT)
  • Alexandrovska Hospital (BG)
  • Tel Aviv University (IL)
  • Hospital Universitario 12 De Octubre (ES)
Corresponding author
Staessen, Jan A
Venue
The Lancet
Publisher
Elsevier BV
Published
1997-09
Volume
350
Issue
9080
Pages
757-764
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W2114634962
Cited by
2,989
References
40
Citations by year
2026: 9 · 2025: 26 · 2024: 27 · 2023: 39 · 2022: 44 · 2021: 56 · 2020: 56 · 2019: 57 · 2018: 91 · 2017: 99 · 2016: 84 · 2015: 80 · 2014: 99 · 2013: 86 · 2012: 107
FWCI
113.15
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations
  • The Lancet (publishedVersion)
  • PubMed (publishedVersion)
  • Ghent University Academic Bibliography (Ghent University) (submittedVersion)
  • LSHTM Research Online (London School of Hygiene and Tropical Medicine) (submittedVersion)
Funders
  • Bayer
  • European Commission
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
  • Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
Keywords
isolated systolic hypertension, older adults, antihypertensive therapy, nitrendipine, enalapril, hydrochlorothiazide, stroke prevention, cardiovascular mortality, cardiovascular complications, blood pressure reduction, sudden death, all-cause mortality, hypertension in the elderly, combination antihypertensive therapy
MeSH terms
Aged, Antihypertensive Agents, Blood Pressure, Calcium Channel Blockers, Cerebrovascular Disorders, Double-Blind Method, Drug Therapy, Combination, Enalapril, Female, Follow-Up Studies, Humans, Hydrochlorothiazide, Hypertension, Male, Morbidity, Nitrendipine, Time Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. https://app.cochat.ai/papers/10.1016/s0140-6736(97)05381-6
The paper
Staessen, J. A., Fagard, R., Thijs, L., Celis, H., Arabidze, G. G., Birkenhäger, W. H., Bulpitt, C. J., de Leeuw, P. W., Dollery, C. T., Fletcher, A. E., Forette, F., Leonetti, G., Nachev, C., O' Brien, E. T., Rosenfeld, J., Rodicio, J. L., Tuomilehto, J., & Zanchetti, A. (1997). Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Lancet. https://doi.org/10.1016/s0140-6736(97)05381-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.